Rodman & Renshaw Starts Rigel Pharma (RIGL) at Market Outperform, Multi-Billion Drug Potential
Tweet Send to a Friend
Rodman & Renshaw initiated coverage on Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) with a Market Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
